Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse

Relapsed acute myeloid leukemia (AML) represents a major therapeutic challenge. Achieving complete remission (CR) with salvage chemotherapy is the first goal of therapy for relapsed AML. However, there is no standard salvage chemotherapy. The current study evaluated outcomes and prognostic factors f...

Descripción completa

Detalles Bibliográficos
Autores principales: Im, Annie, Amjad, Ali, Agha, Mounzer, Raptis, Anastasios, Hou, Jing-Zhou, Farah, Rafic, Lim, Seah, Sehgal, Alison, Dorritie, Kathleen A., Redner, Robert L., McLaughlin, Brian, Shuai, Yongli, Duggal, Shrina, Boyiadzis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838693/
https://www.ncbi.nlm.nih.gov/pubmed/27296947
http://dx.doi.org/10.3727/096504016X14586627440156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838693/
https://www.ncbi.nlm.nih.gov/pubmed/27296947
http://dx.doi.org/10.3727/096504016X14586627440156

Ejemplares similares